Transcode Therapeutics, Inc.

Delivering a Cancer-Free Future

Boston, United States · Founded 2021 · $33.0M raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$33.0M
Last Round
$25.0M Series BOct 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

TransCode Therapeutics is a clinical-stage RNA oncology company developing iron oxide nanoparticle-based therapeutics to treat metastatic cancer. Its lead candidate TTX-MC138 targets microRNA-10b, a master regulator of metastasis, with applicability across 18+ cancer types including breast, pancreatic, and ovarian cancer. The company has received multi-year NIH SBIR Fast-Track funding to support clinical evaluation.

Summary

Transcode Therapeutics, Inc. is a Biotech company based in Boston, United States, founded in 2021. It has raised $33.0M in total across 2 rounds, most recently a $25.0M Series B round in Oct 2025. Investors include CK Life Sciences.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingDebt FinancingApr 2026
$20.0M

Sign up to see all 3 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Transcode Therapeutics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/transcode-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/transcode-therapeutics-inc" alt="Transcode Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>